Bad Influence? U.K. Questions Pharma’s Sway On Health Care System
This article was originally published in The Pink Sheet Daily
House of Commons hearings are scheduled throughout the rest of the year to examine pharmaceutical companies’ influence on all facets of the U.K. health care system. Health committee will focus attention on government agencies, marketing practices and physician education.
You may also be interested in...
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years. This is Part II in the series.
With two landmark advisory committee meetings coming up, the Pink Sheet reflects on some of the most memorable panel meetings over the last 20 years.
NASEM is expected to issue a highly anticipated report in early 2021 on solutions to address Rx vial drug wastage.